Searchable abstracts of presentations at key conferences in endocrinology

ea0020p433 | Diabetes and Cardiovascular | ECE2009

The effect of telmisartan and irbesartan treatments on insulin resistance of patients with type 2 diabetes and hypertension

Tasli Babursah , Oz Gul Ozen , Tuncel Ercan , Guclu Metin , Kiyici Sinem , Imamoglu Sazi

Hyperinsulinemia that occurs due to insulin resistance play an important role on the development of type 2 diabetes and hypertension. It is shown that apart from their angiotensin II receptor blockage effect, telmisartan and irbesartan can activate intracellular hormone receptor PPARγ. Owing to this dual effect, telmisartan and irbesartan can improve cardiovascular risk factors related to insulin resistance. The aim of this study was to compare the effects of telmisartan ...